These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16464404)

  • 21. Molecular profiling of gliomas--time for a regional service.
    Hannan C; Al-Rashid S; Herron B; Conkey D; Harney J; Lyness J; Moss J; Flannery T
    Ulster Med J; 2014 May; 83(2):120-1. PubMed ID: 25075145
    [No Abstract]   [Full Text] [Related]  

  • 22. Long non-coding RNAs: potential molecular biomarkers for gliomas diagnosis and prognosis.
    Wang L; Yu Z; Sun S; Peng J; Xiao R; Chen S; Zuo X; Cheng Q; Xia Y
    Rev Neurosci; 2017 May; 28(4):375-380. PubMed ID: 28107175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the pathway to success: defining subtypes of gliomas for better treatment selection and refining the meaning of success.
    Gilbert MR
    Curr Oncol Rep; 2013 Feb; 15(1):24-6. PubMed ID: 23180217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FGF2 as a potential prognostic biomarker for proneural glioma patients.
    Sooman L; Freyhult E; Jaiswal A; Navani S; Edqvist PH; Pontén F; Tchougounova E; Smits A; Elsir T; Gullbo J; Lennartsson J; Bergqvist M; Ekman S
    Acta Oncol; 2015 Mar; 54(3):385-94. PubMed ID: 25263081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Biomarkers of glioma: recent advance and potential applications].
    Yu SZ; Wang Q
    Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):145-7. PubMed ID: 19575846
    [No Abstract]   [Full Text] [Related]  

  • 26. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
    Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
    Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic and predictive factors for gliomas in adults].
    Frenel JS; Botti M; Loussouarn D; Campone M
    Bull Cancer; 2009 Apr; 96(4):357-67. PubMed ID: 19357011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary brain tumors, delta 24 and tumor metabolism. Interview by Rona Williamson.
    Gilbert MR
    Expert Rev Neurother; 2013 Apr; 13(4):353-5. PubMed ID: 23545051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.
    Wang Q; Wang L; Li D; Deng J; Zhao Z; He S; Zhang Y; Tu Y
    Cancer Epidemiol; 2013 Feb; 37(1):79-84. PubMed ID: 22999822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of low-grade gliomas in children--evolving molecular era and therapeutic insights.
    Khatua S; Wang J; Rajaram V
    Childs Nerv Syst; 2015 May; 31(5):643-52. PubMed ID: 25722047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of molecular biomarkers in gliomas.
    Siegal T
    J Clin Neurosci; 2015 Mar; 22(3):437-44. PubMed ID: 25533211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Updated response assessment criteria for high-grade glioma: beyond the MacDonald criteria.
    Sharma M; Juthani RG; Vogelbaum MA
    Chin Clin Oncol; 2017 Aug; 6(4):37. PubMed ID: 28841799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival and low-grade glioma: the emergence of genetic information.
    Claus EB; Walsh KM; Wiencke JK; Molinaro AM; Wiemels JL; Schildkraut JM; Bondy ML; Berger M; Jenkins R; Wrensch M
    Neurosurg Focus; 2015 Jan; 38(1):E6. PubMed ID: 25552286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma.
    Li X; Zheng J; Chen L; Diao H; Liu Y
    Mol Neurobiol; 2016 Jan; 53(1):577-583. PubMed ID: 25502291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further understanding of the pathology of glioma: implications for the clinic.
    Camelo-Piragua S; Kesari S
    Expert Rev Neurother; 2016 Sep; 16(9):1055-65. PubMed ID: 27228211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nestin Expression Is Associated with Poor Clinicopathological Features and Prognosis in Glioma Patients: an Association Study and Meta-analysis.
    Lv D; Lu L; Hu Z; Fei Z; Liu M; Wei L; Xu J
    Mol Neurobiol; 2017 Jan; 54(1):727-735. PubMed ID: 26768429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarker-based trials in neuro-oncology.
    Ballman KV
    Chin Clin Oncol; 2015 Sep; 4(3):38. PubMed ID: 26408305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
    Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.